Skip to content
Screener

LifeMD, Inc. LFMD Q3 2025 earnings

Reported November 17, 2025 · After market close

Revenue$60.2MBeat by $11.6M
EPS-$0.10Miss by $0.04
Revenue estimate$48.6M
EPS estimate-$0.06

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$48.9M
EPS estimate-$0.14

Financials

Q3 2025

Income statement

See full
Revenue$60.2M+13.0%
Gross profit$52.8M+9.3%
Operating income-$2.0M+50.7%
Net income-$3.8M+18.3%
EPS (diluted)-$0.10+23.1%

Balance sheet

See full
Cash & equivalents$23.8M-27.0%
Total debt$6.5M-68.3%
Total equity$1.3M+117%
Total assets$66.0M-9.1%

Cash flow

See full
CapEx$797.3K+78.0%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$321.96M+48.8%
Enterprise value$304.7M+49.1%
P/S1.8×+0.7×

Profitability

See full
Gross margin84.1%-5.5pp
Operating margin-5.3%-1.7pp
Net margin-5.9%-1.9pp

Returns & leverage

See full
Debt / equity5×—
Current ratio0.7×-0.1×

Segments

By segment

See full
Telehealth$47.3M+17.7%
Telehealth Subscription Revenue$27.3M—

FAQ

When did LifeMD, Inc. report Q3 2025 earnings?
LifeMD, Inc. (LFMD) reported Q3 2025 earnings on November 17, 2025 after market close.
What were LifeMD, Inc.'s Q3 2025 revenue and EPS?
LifeMD, Inc. reported revenue of $60.2M and eps of $-0.10 for Q3 2025.
Did LifeMD, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $48.6M by $11.6M. EPS missed the consensus estimate of $-0.06 by $0.04.
How did LifeMD, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.0% from $53.3M a year earlier and eps grew 28.6% from $-0.14.
Where can I find LifeMD, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-023853) and the 10-Q periodic report (0001493152-25-023906) directly on SEC EDGAR. The filing index links above go to sec.gov.